Viscerosyntheses represent an unrenouncable component of several endos
copic procedures. The extra cost for a laparoscopic viscerosynthesis o
f approximately 2000 DM in the year 1994 are economically well investe
d with regard to a reduced postoperative pain, a reduced amount of pos
toperative analgesics, a faster recovery, and most of all drastically
reduced morbidity of the abdominal wall. The unfortunate structure of
the healthcare system burdens the hospital with additional financial e
xpenditures, thus shifting the profits to the insurance companies. ii
change in this profit structure would allow for a faster spread of eff
icient and promising therapies. Economical studies including patients,
physicians, hospital administrations and insurance companies are cons
idered to be imperative in order to promote the development of efficie
nt therapies.